Educational article
Polymyxins and colistin
Polymyxins interact with lipid A in lipopolysaccharide and disrupt the envelope of selected Gram-negative bacteria. Colistin belongs to this group. Species differ in intrinsic susceptibility; the agent is not universal…
Overview
Polymyxins interact with lipid A in lipopolysaccharide and disrupt the envelope of selected Gram-negative bacteria. Colistin belongs to this group. Species differ in intrinsic susceptibility; the agent is not universal coverage for Gram-negative flora.
Biology and practical meaning
Lipid A modification may be chromosomal or associated with transferable mcr genes. Method selection is particularly important for colistin AST: routine disk diffusion is not a reliable substitute for the recommended MIC method. Gene detection, measured MIC and clinical category are assessed separately.
Spectrum, exposure and AST
Spectrum describes the range of organisms an agent can act against; activity against a particular isolate is assessed separately. Access to the target, target changes, enzymes and efflux can alter activity. Agents in the same class are not completely interchangeable.
Pharmacokinetics describes distribution and elimination; pharmacodynamics links exposure to effect. Blood concentrations and exposure at the infection site can differ. A lower MIC number for a different antibiotic therefore does not establish superior clinical activity.
S, I and R are interpreted using a current standard for the organism–agent pair. Under EUCAST, I means susceptible with increased exposure. It does not mean resistant and does not independently specify a treatment regimen. Decisions also depend on the site, patient, contraindications, interactions and current guidance. This article explains mechanisms and terminology. The 2025 AWaRe classification concerns use policy, while the 2022 AWaRe book has subsequent updates; neither replaces an individual AST result.
Teaching example: from finding to conclusion
Teaching example: a large zone around a colistin disk is incorrectly treated as proof of susceptibility. Routine disk diffusion does not reliably replace the recommended MIC assessment for this agent.
Check method suitability and QC before interpretation. mcr detection is assessed separately from measured MIC. Genotype–phenotype disagreement calls for investigation, including identification and analytical quality, rather than choosing the convenient result. This example supplies no colistin regimen.
Sources
Read next
Educational material from AMR Atlas. Does not replace clinical guidance or laboratory procedures.